American Society of Nephrology

Advertisement

Available Now: JASN COVID-19 Articles - All articles are Open Access - including this most recent one:

AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype

Published Ahead of Print

You have accessRestricted Access
Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells
Simon Melderis, Julia Hagenstein, Matthias Tobias Warkotsch, Julien Dang, Georg Rudolf Herrnstadt, Christoph Benjamin Niehus, Katrin Neumann, Ulf Panzer, Carmen Berasain, Matias A. Avila, Pierre-Louis Tharaux, Gisa Tiegs and Oliver M. Steinmetz

JASN July 2020, ASN.2019111215; DOI: https://doi.org/10.1681/ASN.2019111215

Add to Selected Citations
You have accessRestricted Access
Sympathetic Overactivity in CKD Disrupts Buffering of Neurotransmission by Endothelium-Derived Hyperpolarizing Factor and Enhances Vasoconstriction
Wei Cao, Liling Wu, Xiaodong Zhang, Jing Zhou, Jian Wang, Zhichen Yang, Huanjuan Su, Youhua Liu, Christopher S. Wilcox and Fan Fan Hou

JASN July 2020, ASN.2020030234; DOI: https://doi.org/10.1681/ASN.2020030234

Add to Selected Citations
Open Access
Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury
Chia Siang Kow and Syed Shahzad Hasan

JASN July 2020, ASN.2020050640; DOI: https://doi.org/10.1681/ASN.2020050640

Add to Selected Citations
Open Access
Authors’ Reply
Daniel Batlle, Maria Jose Soler, Paul A. Welling, Sundararaman Swaminathan and on behalf of the COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group*

JASN July 2020, ASN.2020060799; DOI: https://doi.org/10.1681/ASN.2020060799

Add to Selected Citations
You have accessRestricted Access
Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy
Akiko Takahata, Satoko Arai, Emiri Hiramoto, Kento Kitada, Rina Kato, Yuko Makita, Hitoshi Suzuki, Junichiro Nakata, Kimi Araki, Toru Miyazaki and Yusuke Suzuki

JASN July 2020, ASN.2019100987; DOI: https://doi.org/10.1681/ASN.2019100987

Add to Selected Citations
You have accessRestricted Access
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial
Manjula Kurella Tamura, Sarah A. Gaussoin, Nicholas M. Pajewski, Gordon J. Chelune, Barry I. Freedman, Tanya R. Gure, William E. Haley, Anthony A. Killeen, Suzanne Oparil, Stephen R. Rapp, Dena E. Rifkin, Mark Supiano, Jeff D. Williamson, Daniel E. Weiner and for the SPRINT Research Group

JASN June 2020, ASN.2020010038; DOI: https://doi.org/10.1681/ASN.2020010038

Add to Selected Citations

EDITOR'S CHOICE ARTICLES:

These articles were chosen by the Editor-in-Chief due to their anticipated impact on kidney science.

Follow JASN on Twitter